RT Book, Section A1 Uemura, Marc A1 Krishnan, Sunil A1 Kaseb, Ahmed O. A1 Bhadkamkar, Nishin A. A1 Javle, Milind M. A1 Avritscher, Rony A2 Kantarjian, Hagop M. A2 Wolff, Robert A. SR Print(0) ID 1126742315 T1 Hepatocellular Carcinoma T2 The MD Anderson Manual of Medical Oncology, 3e YR 2016 FD 2016 PB McGraw-Hill Medical PP New York, NY SN 9780071847940 LK hemonc.mhmedical.com/content.aspx?aid=1126742315 RD 2024/03/29 AB Hepatobiliary malignancies comprise a diverse group of tumors, including hepatocellular carcinoma (HCC), variants such as fibrolamellar HCC (FLHCC) and cholangiocellular carcinoma, cholangiocarcinoma, carcinoma of the gallbladder, and rare cancers such as sarcoma, angiosarcoma, and hepatoblastoma. The relative frequency of these tumors is shown in Table 22-1. The estimated new cases and deaths from liver and intrahepatic bile duct cancer in the United States in 2014 totaled 33,190 and 23,000, respectively (1).